Optimization and Validation of a Virtual Reality Orientation and Mobility Test for Inherited Retinal Degenerations.


Journal

Translational vision science & technology
ISSN: 2164-2591
Titre abrégé: Transl Vis Sci Technol
Pays: United States
ID NLM: 101595919

Informations de publication

Date de publication:
03 01 2023
Historique:
entrez: 30 1 2023
pubmed: 31 1 2023
medline: 2 2 2023
Statut: ppublish

Résumé

To optimize a virtual reality (VR) orientation and mobility (O&M) test of functional vision in patients with inherited retinal degenerations (IRDs). We developed an O&M test using commercially available VR hardware and custom-generated software. Normally sighted subjects (n = 20, ages = 14-67 years) and patients with IRDs (n = 29, ages = 15-63 years) participated. Individuals followed a dim red arrow path to a "course exit," while trying to identify nine obstacles adjacent to, or directly in their path. Dark-adapted subjects completed 35 randomly selected VR courses at increasing luminances, twice per luminance step, binocularly, and uni-ocularly. Performance was graded automatically by the software. Patients with IRD completed a modified Visual Function Questionnaire (VFQ). Normally sighted subjects identified approximately 50% of the obstacles at the dimmest course luminance. Except for two patients with IRD with poor vision, all patients were able to complete the test, although they required brighter (by >2 log units) luminances to identify 50% of the obstacles. In a single-luminance screening test in which normal subjects detected at least eight of nine objects, most patients with IRD underperformed; their performance related to disease severity, as measured by visual acuity, kinetic visual field extent, and VFQ scores. Test-retest differences in object detection were similar to the differences between the two eyes (±2 SD = ±2 objects). This VR-O&M test was able to distinguish subjects with IRDs from normal subjects reliably and reproducibly. This easily implemented, flexible, and objectively scored VR-O&M test promises to become a useful tool to assess the impact that IRDs and their treatments have on functional vision.

Identifiants

pubmed: 36716040
pii: 2785319
doi: 10.1167/tvst.12.1.28
pmc: PMC9896841
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

28

Références

Clin Ophthalmol. 2021 Mar 02;15:939-952
pubmed: 33688162
Hum Factors. 1978 Jun;20(3):273-86
pubmed: 567170
Am J Ophthalmol. 2019 Mar;199:58-70
pubmed: 30268864
Clin Exp Ophthalmol. 2018 Apr;46(3):247-259
pubmed: 28697537
Clin Exp Optom. 2020 Jul;103(4):434-448
pubmed: 31838758
Hear Res. 2014 Apr;310:60-8
pubmed: 24524865
Am J Ophthalmol. 2021 Oct;230:12-47
pubmed: 34000280
Optom Vis Sci. 2016 Sep;93(9):1127-36
pubmed: 27254810
J Vis. 2016 Dec 1;16(15):5
pubmed: 27919101
Invest Ophthalmol Vis Sci. 2017 May 1;58(5):2609-2622
pubmed: 28510626
Semin Pediatr Neurol. 2019 Oct;31:30-40
pubmed: 31548022
J Glaucoma. 2020 Feb;29(2):86-91
pubmed: 31790067
Am J Optom Physiol Opt. 1982 May;59(5):413-26
pubmed: 7102800
Nat Med. 2022 May;28(5):1014-1021
pubmed: 35379979
Clin Exp Optom. 2016 May;99(3):227-32
pubmed: 26804484
Am J Occup Ther. 2015 Jan-Feb;69(1):6901290010p1-8
pubmed: 25553750
ACM Trans Appl Percept. 2007 Jan;4(1):8
pubmed: 18167511
J Neural Eng. 2007 Mar;4(1):S102-7
pubmed: 17325408
N Engl J Med. 2008 May 22;358(21):2231-9
pubmed: 18441371

Auteurs

Jean Bennett (J)

Scheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Elena M Aleman (EM)

Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Katherine H Maguire (KH)

Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Jennifer Nadelmann (J)

Scheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.

Mariejel L Weber (ML)

Scheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

William M Maguire (WM)

Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Ayodele Maja (A)

Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.

Erin C O'Neil (EC)

Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Division of Ophthalmology at the Children's Hospital of Philadelphia of the Department of Ophthalmology, Philadelphia, PA, USA.

Albert M Maguire (AM)

Scheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Division of Ophthalmology at the Children's Hospital of Philadelphia of the Department of Ophthalmology, Philadelphia, PA, USA.

Alexander J Miller (AJ)

Neurology Virtual Reality Laboratory of the Department of Neurology, University of Pennsylvania, Philadelphia, PA, USA.

Tomas S Aleman (TS)

Scheie Eye Institute at the Perelman Center for Advanced Medicine, Philadelphia, PA, USA.
Center for Advanced Retinal and Ocular Therapeutics at the University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA.
Division of Ophthalmology at the Children's Hospital of Philadelphia of the Department of Ophthalmology, Philadelphia, PA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH